Five Star Equities Provides Stock Research on Oncolytics Biotech and XOMA
Continue ReadingTag: stock-market
U.S. Food and Drug Administration Approved 30% More Drugs in 2012 Than the Year Previous
RDInvesting Provides Stocks Research on Protalix BioTherapeutics and Supernus Pharmaceuticals
Continue Reading
New Programs Designed to Speed up Approval Process a Key Factor in Biotech Industry-s Growth in 2012
Five Star Equities Provides Stock Research on ImmunoCellular and Nektar
Continue Reading
Refiners Battle Sharp Increase in Renewable Fuel Credits in 2013
RDInvesting Provides Stock Research on Delek US Holdings and Murphy Oil
Continue Reading
Programs by the FDA Designed to Speed Up Approval Process for Critical Drugs a Key Factor in Biotech-s Industry Success
Five Star Equities Provides Stock Research on ArQule and Vanda Pharmaceuticals
Continue Reading
China and the United Kingdom Expected to Be Major Importers of Coal in 2013
RDInvesting Provides Stock Research on Natural Resource Partners and Walter Energy
Continue Reading
Long-Term Demand for Uranium to Be Driven by Emerging Nation – Miners Could Receive Boost From End of Russia-s Disarmament Treaty
Five Star Equities Provides Stock Research on Uranium Energy and Uranium Resources
Continue Reading
United Kingdom Coal Imports Expected to Rise Sharply After Closure of Two Major Mines
RDInvesting Provides Stock Research on Cloud Peak Energy and CONSOL Energy
Continue Reading
Biotech Industry Looks to Benefit From FDA-s New “Breakthrough” Designation
Five Star Equities Provides Stock Research on Athersys and Zogenix
Continue Reading
U.S. Oil Refiners Battle Lower Margins Due to Rising Renewable Fuel Credits
RDInvesting Provides Stock Research on Alon USA Energy and PBF Energy
Continue Reading